Rates Rise and Homebuilders Sinks, Plus the MedTech Stock Getting Skinnier, Thanks to the Weight Loss Drug Boom 9/5/23
Homebuilder stocks kick off the week on shaky foundation, as interest rates resume their march higher. What the moves say about the strength of the markets heading into fall. Plus one analyst downgrading shares of ResMed as the boom in weight loss drugs could lead to lower demand for sleep apnea devices. We look at the other side effects of people slimming down and the stocks that could get impacted. Fast Money Disclaimer